Use of Danshensu, Notoginsenoside R1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder

摘要

The present invention relates to a new use of traditional Chinese drug products of Danshensu (DLA), Notoginsenoside R1 (R1) and their combination, in particular to the therapeutic and preventive effects of DLA, R1 and their combination on the diseases caused by microcirculation disorder.

主权项

1. A method for treating at least one disease caused by a microcirculation disorder resulting from ischemia-reperfusion in a subject, the method comprising administering an effective amount of a first medicine prepared from a first combination of Danshensu and Notoginsenoside R1 to the subject, the Danshensu having a weight ratio relative to the Notoginsenoside R1 in a range of about 1:4 to about 4:1, wherein the at least one disease caused by the microcirculation disorder resulting from ischemia-reperfusion is selected from the group consisting of: pollinosis, asthma, diarrhea, hypertension, infection, and traumatic injury.